S, 5 ml of CSF was digested with PNGase F (New England

S, 5 ml of CSF was digested with PNGase F (New England Biolabs) or neuraminidase (Roche, 1585886) as stated by the manufacturers and subjected to a 2D-immunoblot.Neuraminidase AssayTo quantitatively assess the neuraminidase level in CSF, a commercially available Neuraminidase Assay kit (Molecular probes) was used according to the manufacturer’s instructions. CSF was measured in a 1+1 dilution.Characterization of Serpin A1 Isoforms LC-MS/MSSamples were subjected to proteolytic digestion on a ProGest (Genomic Solutions) workstation as follows: Samples were reduced with DTT at 60uC and then cooled to room temperature. Furthermore, samples were alkylated with iodoacetamide and subsequently incubated at 37uC for 4 h in the presence of trypsin. Formic acid was added to stop the reaction and the supernatant was analyzed directly by nano LC/MS/MS on a ThermoFisher LTQ Orbitrap XL. 30 ml of hydrolysate was loaded onto a 5 mm675 mm ID C12 (Jupiter Proteo, Phenomenex) vented column at a flow-rate of 10 mL/min. Gradient elution was over a 15 cm675 mm ID C12 column at 300 nL/min. A 30 min gradient was employed. The mass spectrometer was operated in data-dependent mode and the six most abundant ions were selected for MS/MS. The Orbitrap MS scan was performed at 60,000 FWHM resolutions. MS/MS data were searched using a local copy of Mascot (www.matrixscience.com). The parameters for all LC/MS/MS 26001275 searches were as follows: Type of search: MS/ MS ion search. Taxonomy: human. Enzyme: trypsin. Fixed modifications: HIV-RT inhibitor 1 carbamidomethyl (C). 24272870 Variable modifications: oxidation (M), acetyl (N-term), pyro-glu (N-term Q), methyl (various), deamidation (NQ), PO4 (STY). Mass values: monoisotopic. Protein mass: unrestricted. Peptide mass tolerance: 610 ppm (Orbitrap). Fragment mass tolerance: 60.5 Da (LTQ). Maximum missed cleavages: 2.Calculations and StatisticsBand volumes of immunoblots (adjusted for membrane background) were purchase Bromopyruvic acid determined using the Quantity One software (BioRad). Analysis for significant differences in a given parameter between all tested groups or between two groups were calculated by Kruskal-Wallis test or Mann-Whitney test. Correlation between parameters was examined applying Spearman rank correlation. Pvalues p#0.05 were considered to be significant. For ROC analysis, p-values p#0.01 were considered significant (sigma plot software 10.0). Standard measures of diagnostic test validity such as sensitivity and specificity were calculated for the diagnostic groups [58].Supporting InformationFigure S1 Representative Serpin A1-blots of PNGase Ftreated CSF of PD and PDD. Abbreviations: PD = Parkinson’s disease, PDD = Parkinson’s disease dementia (TIF)ImmunoblottingEqual amounts of total protein or equal volumes (CSF) were denatured and subjected to a SDS-PAGE in 12 polyacrylamide gels. Proteins were transferred onto PVDF membranes (Millipore, USA), correct transfer was checked by Ponceau Red S staining. The membranes were incubated with the respective primary antibody (see below) followed by incubation with HRP conjugated secondary antibodies. Signal detection was performed by enhanced chemiluminescence (GE healthcare) on a CCD-camera. For 2D-immunoblotting, strips were equilibrated for 2620 min in 6 M urea, 125 mM Tris-HCL pH 7.85, 3 SDS and 20AcknowledgmentsWe thank all physicians notifying suspect cases to our clinics. Special thanks go to Marc Bothe for neuropsychological testing of the patients. Our colleague Professor Tuula Pirttila passed away duri.S, 5 ml of CSF was digested with PNGase F (New England Biolabs) or neuraminidase (Roche, 1585886) as stated by the manufacturers and subjected to a 2D-immunoblot.Neuraminidase AssayTo quantitatively assess the neuraminidase level in CSF, a commercially available Neuraminidase Assay kit (Molecular probes) was used according to the manufacturer’s instructions. CSF was measured in a 1+1 dilution.Characterization of Serpin A1 Isoforms LC-MS/MSSamples were subjected to proteolytic digestion on a ProGest (Genomic Solutions) workstation as follows: Samples were reduced with DTT at 60uC and then cooled to room temperature. Furthermore, samples were alkylated with iodoacetamide and subsequently incubated at 37uC for 4 h in the presence of trypsin. Formic acid was added to stop the reaction and the supernatant was analyzed directly by nano LC/MS/MS on a ThermoFisher LTQ Orbitrap XL. 30 ml of hydrolysate was loaded onto a 5 mm675 mm ID C12 (Jupiter Proteo, Phenomenex) vented column at a flow-rate of 10 mL/min. Gradient elution was over a 15 cm675 mm ID C12 column at 300 nL/min. A 30 min gradient was employed. The mass spectrometer was operated in data-dependent mode and the six most abundant ions were selected for MS/MS. The Orbitrap MS scan was performed at 60,000 FWHM resolutions. MS/MS data were searched using a local copy of Mascot (www.matrixscience.com). The parameters for all LC/MS/MS 26001275 searches were as follows: Type of search: MS/ MS ion search. Taxonomy: human. Enzyme: trypsin. Fixed modifications: carbamidomethyl (C). 24272870 Variable modifications: oxidation (M), acetyl (N-term), pyro-glu (N-term Q), methyl (various), deamidation (NQ), PO4 (STY). Mass values: monoisotopic. Protein mass: unrestricted. Peptide mass tolerance: 610 ppm (Orbitrap). Fragment mass tolerance: 60.5 Da (LTQ). Maximum missed cleavages: 2.Calculations and StatisticsBand volumes of immunoblots (adjusted for membrane background) were determined using the Quantity One software (BioRad). Analysis for significant differences in a given parameter between all tested groups or between two groups were calculated by Kruskal-Wallis test or Mann-Whitney test. Correlation between parameters was examined applying Spearman rank correlation. Pvalues p#0.05 were considered to be significant. For ROC analysis, p-values p#0.01 were considered significant (sigma plot software 10.0). Standard measures of diagnostic test validity such as sensitivity and specificity were calculated for the diagnostic groups [58].Supporting InformationFigure S1 Representative Serpin A1-blots of PNGase Ftreated CSF of PD and PDD. Abbreviations: PD = Parkinson’s disease, PDD = Parkinson’s disease dementia (TIF)ImmunoblottingEqual amounts of total protein or equal volumes (CSF) were denatured and subjected to a SDS-PAGE in 12 polyacrylamide gels. Proteins were transferred onto PVDF membranes (Millipore, USA), correct transfer was checked by Ponceau Red S staining. The membranes were incubated with the respective primary antibody (see below) followed by incubation with HRP conjugated secondary antibodies. Signal detection was performed by enhanced chemiluminescence (GE healthcare) on a CCD-camera. For 2D-immunoblotting, strips were equilibrated for 2620 min in 6 M urea, 125 mM Tris-HCL pH 7.85, 3 SDS and 20AcknowledgmentsWe thank all physicians notifying suspect cases to our clinics. Special thanks go to Marc Bothe for neuropsychological testing of the patients. Our colleague Professor Tuula Pirttila passed away duri.